These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Regulation of conditionally licensed biologicals in the United States. Hill RE. Dev Biol (Basel); 2004; 117():147-52. PubMed ID: 15597632 [Abstract] [Full Text] [Related]
3. Regulations for vaccines against emerging infections and agrobioterrorism in the United States of America. Elsken LA, Carr MY, Frana TS, Brake DA, Garland T, Smith K, Foley PL. Rev Sci Tech; 2007 Aug; 26(2):429-41. PubMed ID: 17892163 [Abstract] [Full Text] [Related]
4. Licensing veterinary biologics in the United States. Espeseth DA. Dev Biol Stand; 1992 Aug; 79():17-25. PubMed ID: 1286752 [Abstract] [Full Text] [Related]
6. Translating research into licensed vaccines and validated and licensed diagnostic tests. Hill RE, Foley PL, Clough NE, Ludemann LR, Murtle DC. Dev Biol (Basel); 2013 Aug; 135():53-8. PubMed ID: 23689883 [Abstract] [Full Text] [Related]
7. History of regulatory requirements for poultry biologics in the United States, 1970s to 1990s. Espeseth DA, Lasher H. Avian Dis; 2013 Jun; 57(2):167-71. PubMed ID: 24689169 [Abstract] [Full Text] [Related]
8. Canadian regulatory requirements for recombinant fish vaccines. Sethi MS, Gifford GA, Samagh BS. Dev Biol Stand; 1997 Jun; 90():347-53. PubMed ID: 9270863 [Abstract] [Full Text] [Related]
9. Regulation of veterinary biological products for fish in the United States. Birnbaum NG. Dev Biol Stand; 1997 Jun; 90():335-40. PubMed ID: 9270861 [Abstract] [Full Text] [Related]
10. Regulatory considerations for marker vaccines and diagnostic tests in the U.S. Foley PL, Hill RE. Biologicals; 2005 Dec; 33(4):253-6. PubMed ID: 16257538 [Abstract] [Full Text] [Related]
13. Regulatory requirements for vaccine authorisation. Jones PG, Cowan G, Gravendyck M, Nagata T, Robinson S, Waits M. Rev Sci Tech; 2007 Aug; 26(2):379-93. PubMed ID: 17892159 [Abstract] [Full Text] [Related]
14. The American manufacturer's view on the EEC texts and harmonization. Draayer HA, Hilsabeck LJ, Miller RH. Dev Biol Stand; 1992 Aug; 79():77-83. PubMed ID: 1286768 [Abstract] [Full Text] [Related]
15. [Diagnostic kits in parasitology: which controls?]. Rossi P. Parassitologia; 2004 Jun; 46(1-2):145-9. PubMed ID: 15305705 [Abstract] [Full Text] [Related]
16. Alternative Methods to Reduce, Refine, and Replace the Use of Animals In the Development and Testing of Veterinary Biologics in The United States; a Strategic Priority. Hill RE. Procedia Vaccinol; 2011 Jun; 5():141-145. PubMed ID: 32288916 [Abstract] [Full Text] [Related]
18. Regulatory issues surrounding the temporary authorisation of animal vaccination in emergency situations: the example of bluetongue in Europe. Saegerman C, Hubaux M, Urbain B, Lengelé L, Berkvens D. Rev Sci Tech; 2007 Aug; 26(2):395-413. PubMed ID: 17892160 [Abstract] [Full Text] [Related]
19. Comparison of requirements in the European Union and United States of America for pre-clinical viral safety testing of veterinary vaccines. Sheridan S, Coughlin J. Biologicals; 2010 May; 38(3):340-5. PubMed ID: 20400329 [Abstract] [Full Text] [Related]
20. Development and approval of vaccines in the United States. Botstein P. Isr J Med Sci; 1986 May; 22(3-4):268-71. PubMed ID: 3528047 [Abstract] [Full Text] [Related] Page: [Next] [New Search]